chr6:30489509:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr6:30,457,286-30,461,971 |
hg38 | chr6:30,489,509-30,494,194 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.004 | renal cell carcinoma | NA | BeFree | Detail | |
0.002 | squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Dilated | Repression of CELF-mediated splicing activity via expression of a nuclear domina... | BeFree | 25894229 | Detail |
0.001 | hypertrophic cardiomyopathy | NA | BeFree | Detail | |
<0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
0.004 | hepatitis B | Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated... | BeFree | 22015712 | Detail |
0.007 | celiac disease | NA | BeFree | Detail | |
0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.002 | Primary biliary cirrhosis | NA | BeFree | Detail | |
<0.001 | Cholangitis, Sclerosing | NA | BeFree | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
<0.001 | hemophilia B | NA | BeFree | Detail | |
0.002 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
0.004 | colorectal carcinoma | Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-... | BeFree | 25461612 | Detail |
<0.001 | Colorectal Neoplasms | NA | BeFree | Detail | |
0.002 | common variable immunodeficiency | A strong trend of association was also seen for 38 SNPs (P < 5 × 10(-5)) in the ... | BeFree | 25678086 | Detail |
0.003 | coronary aneurysm | NA | BeFree,GAD | Detail | |
<0.001 | cowpox | NA | BeFree | Detail | |
0.002 | Crohn Disease | NA | BeFree | Detail | |
<0.001 | cystic fibrosis | MHC class II transcripts were reduced in CF with a sevenfold decrease in HLA-DQβ... | BeFree | 25146850 | Detail |
0.001 | Cytomegalovirus Infections | Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of s... | BeFree | 25356901 | Detail |
<0.001 | Demyelinating Diseases | NA | BeFree | Detail | |
<0.001 | dental caries | NA | BeFree | Detail | |
<0.001 | Mental Depression | NA | BeFree | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
<0.001 | dermatitis herpetiformis | NA | BeFree | Detail | |
<0.001 | Dermatitis, Atopic | NA | BeFree | Detail | |
<0.001 | contact dermatitis | NA | BeFree | Detail | |
<0.001 | dermatomyositis | NA | BeFree | Detail | |
0.001 | scleroderma | NA | BeFree | Detail | |
0.009 | Diabetes | Here we studied MHC class II expression on beta cells in nonobese diabetic mice ... | BeFree | 25959978 | Detail |
0.009 | Diabetes | We demonstrate significant power in International Genetics & Translational Resea... | BeFree | 26479416 | Detail |
0.009 | diabetes mellitus | Here we studied MHC class II expression on beta cells in nonobese diabetic mice ... | BeFree | 25959978 | Detail |
0.009 | diabetes mellitus | We demonstrate significant power in International Genetics & Translational Resea... | BeFree | 26479416 | Detail |
0.029 | Diabetes Mellitus, Insulin-Dependent | Susceptibility to type 1 diabetes (T1D) is strongly associated with MHC class II... | BeFree | 25405480 | Detail |
0.029 | Diabetes Mellitus, Insulin-Dependent | Insulin is a major autoantigen in T1D, but how its peptides are presented to CD4... | BeFree | 25831495 | Detail |
0.029 | Diabetes Mellitus, Insulin-Dependent | Our study indicates that MHC class II molecules may play an important role in be... | BeFree | 25959978 | Detail |
0.002 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
<0.001 | Muscular Dystrophy, Duchenne | NA | BeFree | Detail | |
<0.001 | Eczema | NA | BeFree | Detail | |
0.004 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | Toxic Epidermal Necrolysis | NA | BeFree | Detail | |
<0.001 | Erysipelothrix infection | NA | BeFree | Detail | |
<0.001 | Exanthema | NA | BeFree | Detail | |
<0.001 | Disorder of eye | NA | BeFree | Detail | |
<0.001 | Fatigue | NA | BeFree | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
<0.001 | Gingival Diseases | NA | BeFree | Detail | |
0.001 | glioblastoma | NA | BeFree | Detail | |
0.002 | Glioma | In situ PLA showed that the IDH1R132H epitope colocalizes with MHC class II in I... | BeFree | 25555220 | Detail |
<0.001 | glomerulonephritis | NA | BeFree | Detail | |
0.001 | IgA glomerulonephritis | NA | BeFree | Detail | |
<0.001 | goiter | NA | BeFree | Detail | |
0.012 | Graft-vs-Host Disease | HLA-E*0103/E*0103 genotype is associated with lower risk of graft-versus-host di... | BeFree,GAD,LHGDN | 25420801 | Detail |
<0.001 | chronic granulomatous disease | NA | BeFree | Detail | |
0.005 | Graves Disease | NA | BeFree | Detail | |
<0.001 | Hay fever | NA | BeFree | Detail | |
<0.001 | Heart failure | NA | BeFree | Detail | |
0.001 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Helminthiasis | NA | BeFree | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
0.002 | hemochromatosis | NA | BeFree | Detail | |
<0.001 | Hemophilia A | NA | BeFree | Detail | |
<0.001 | hepatitis | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
0.004 | hepatitis B | NA | BeFree | Detail | |
<0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.002 | hepatitis C | NA | BeFree | Detail | |
0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Herpesviridae Infections | NA | BeFree | Detail | |
<0.001 | Malignant histiocytosis | NA | BeFree | Detail | |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
<0.001 | hyperinsulinism | NA | BeFree | Detail | |
<0.001 | hypothyroidism | NA | BeFree | Detail | |
0.002 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
<0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
0.002 | influenza | Efficient vaccine against pandemic influenza: combining DNA vaccination and targ... | BeFree | 25818107 | Detail |
<0.001 | iridocyclitis | NA | BeFree | Detail | |
0.001 | arthropathy | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
<0.001 | leishmaniasis | NA | BeFree | Detail | |
0.001 | leprosy | NA | BeFree | Detail | |
0.003 | leukemia | NA | BeFree | Detail | |
0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
0.001 | Adult T-Cell Lymphoma/Leukemia | Our results suggest that therapeutic approaches using combined targeting of STAT... | BeFree | 26025667 | Detail |
<0.001 | lichen planus | NA | BeFree | Detail | |
<0.001 | listeriosis | NA | BeFree | Detail | |
<0.001 | Liver neoplasms | NA | BeFree | Detail | |
<0.001 | Chronic Obstructive Airway Disease | NA | BeFree | Detail | |
0.002 | Lupus Vulgaris | NA | BeFree | Detail | |
0.002 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
0.021 | Lupus Erythematosus, Systemic | On the basis of these findings, we propose that factors enabling a β2GPI-reactiv... | BeFree,GAD | 25555913 | Detail |
0.021 | Lupus Erythematosus, Systemic | Among them there are a number of pSS associated gene polymorphisms including the... | BeFree,GAD | 26320362 | Detail |
<0.001 | lupus nephritis | NA | BeFree | Detail | |
0.003 | lymphoma | NA | BeFree | Detail | |
<0.001 | reticulosarcoma | NA | BeFree | Detail | |
<0.001 | lymphopenia | NA | BeFree | Detail | |
0.002 | malaria | NA | BeFree | Detail | |
<0.001 | Malaria, Falciparum | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of stomach | We identified that the HLA-E and HLA-F in gastric cancer independently affected ... | BeFree | 25862890 | Detail |
<0.001 | paroxysmal nocturnal hemoglobinuria | NA | BeFree | Detail | |
<0.001 | measles | NA | BeFree | Detail | |
0.020 | melanoma | Exploration of peptides bound to MHC class I molecules in melanoma. | BeFree,LHGDN | 25645385 | Detail |
0.020 | melanoma | Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Spec... | BeFree,LHGDN | 26183926 | Detail |
<0.001 | Meleda Disease | NA | BeFree | Detail | |
<0.001 | mitral valve insufficiency | NA | BeFree | Detail | |
<0.001 | mitral valve stenosis | NA | BeFree | Detail | |
<0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
0.003 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,GAD | Detail | |
0.002 | multiple myeloma | Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and... | BeFree | 25920521 | Detail |
0.011 | multiple sclerosis | Data including and excluding Major Histocompatibility Complex (MHC) markers were... | BeFree | 24099750 | Detail |
<0.001 | myopathy | A mild line of MHC-CELFΔ mice that expresses a lower level of the dominant negat... | BeFree | 25894229 | Detail |
<0.001 | muscular dystrophy | NA | BeFree | Detail | |
0.003 | myasthenia gravis | NA | BeFree | Detail | |
<0.001 | Mycoplasma Infections | NA | BeFree | Detail | |
<0.001 | myocardial infarction | NA | BeFree | Detail | |
<0.001 | myocarditis | NA | BeFree | Detail | |
0.001 | myositis | NA | BeFree | Detail | |
<0.001 | narcolepsy | NA | BeFree | Detail | |
0.002 | Neoplasm Metastasis | Our results also showed that the expression of HLA-E was significantly correlate... | BeFree | 25461612 | Detail |
<0.001 | nephritis | NA | BeFree | Detail | |
0.003 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | obesity | An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ ... | BeFree | 25310975 | Detail |
<0.001 | osteomyelitis | NA | BeFree | Detail | |
0.001 | osteosarcoma | Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphi... | BeFree | 25000484 | Detail |
0.001 | osteosarcoma | Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk... | BeFree | 25230787 | Detail |
<0.001 | ovarian carcinoma | The levels of HLA-E protein expression in SOC patients with the HLA-E*0103 allel... | BeFree | 25711417 | Detail |
<0.001 | Pancreatic Neoplasm | NA | BeFree | Detail | |
<0.001 | pancytopenia | NA | BeFree | Detail | |
<0.001 | tropical spastic paraparesis | NA | BeFree | Detail | |
0.120 | parapsoriasis | NA | CTD_human | Detail | |
<0.001 | Parasitic Diseases | NA | BeFree | Detail | |
<0.001 | bullous pemphigoid | NA | BeFree | Detail | |
<0.001 | pemphigus | NA | BeFree | Detail | |
<0.001 | pemphigus vulgaris | NA | BeFree | Detail | |
<0.001 | Periodontal Diseases | NA | BeFree | Detail | |
<0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | Periodontitis, Juvenile | NA | BeFree | Detail | |
0.002 | pre-eclampsia | NA | GAD | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
<0.001 | Pregnancy Complications | NA | BeFree | Detail | |
<0.001 | Prostatic Neoplasms | NA | BeFree | Detail | |
<0.001 | Protein Deficiency | NA | BeFree | Detail | |
0.008 | psoriasis | In addition, we show that the MHC and TNIP1 regions are significantly different ... | BeFree,GAD | 25481369 | Detail |
0.008 | psoriasis | Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism ... | BeFree,GAD | 26013045 | Detail |
<0.001 | Psychotic Disorders | Replication and cross-phenotype study based upon schizophrenia GWASs data in the... | BeFree | 24888570 | Detail |
<0.001 | pulmonary fibrosis | NA | BeFree | Detail | |
<0.001 | Henoch-Schoenlein purpura | NA | BeFree | Detail | |
<0.001 | Respiratory Syncytial Virus Infections | A model is therefore proposed in which the host upregulates MHC-I expression dur... | BeFree | 25972545 | Detail |
<0.001 | retinal vascular occlusion | NA | BeFree | Detail | |
<0.001 | retinoblastoma | NA | BeFree | Detail | |
<0.001 | Retroviridae Infections | NA | BeFree | Detail | |
<0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | rheumatic heart disease | NA | BeFree | Detail | |
<0.001 | rosacea | In addition, three HLA alleles, all MHC class II proteins, were significantly as... | BeFree | 25695682 | Detail |
0.002 | sarcoidosis | NA | BeFree | Detail | |
0.003 | schizophrenia | Replication and cross-phenotype study based upon schizophrenia GWASs data in the... | BeFree | 24888570 | Detail |
0.003 | systemic scleroderma | NA | BeFree | Detail | |
<0.001 | Dermatologic disorders | NA | BeFree | Detail | |
0.011 | ankylosing spondylitis | The human MHC class I protein HLA-B*27:05 is statistically associated with ankyl... | BeFree,GAD | 25615938 | Detail |
<0.001 | Stevens-Johnson syndrome | NA | BeFree | Detail | |
<0.001 | Streptococcal Infections | NA | BeFree | Detail | |
<0.001 | Cerebrovascular accident | However, the potential application of pMHC to human stroke is limited by the nee... | BeFree | 24122483 | Detail |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
<0.001 | Giant Cell Arteritis | NA | BeFree | Detail | |
0.001 | thymoma | NA | BeFree | Detail | |
<0.001 | Thyroid Diseases | NA | BeFree | Detail | |
0.002 | thyroiditis | NA | BeFree | Detail | |
<0.001 | Toxoplasmosis, Congenital | NA | BeFree | Detail | |
0.001 | Chagas disease | Taken together, our results provide evidence that the protozoan T. cruzi specifi... | BeFree | 24752321 | Detail |
0.003 | tuberculosis | NA | BeFree | Detail | |
0.001 | Tuberculosis, Pulmonary | NA | BeFree | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
<0.001 | typhoid fever | NA | BeFree | Detail | |
<0.001 | uveitis | NA | BeFree | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
<0.001 | vasculitis | A genome-wide significant association with cryoglobulin-related vasculitis was i... | BeFree | 25030430 | Detail |
0.006 | Virus Diseases | HLA-C is unique among the classical MHC class I molecules for its role in the co... | BeFree | 25083782 | Detail |
0.001 | vitiligo | Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism ... | BeFree | 26013045 | Detail |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.002 | diffuse large B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Immunoblastic Large-Cell Lymphoma | NA | BeFree | Detail | |
0.002 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Bronchial Hyperreactivity | NA | BeFree | Detail | |
0.005 | gestational diabetes | NA | BeFree,GAD | Detail | |
<0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
<0.001 | Arthritis, Reactive | NA | BeFree | Detail | |
<0.001 | polymyositis | NA | BeFree | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Primary Sj�gren's syndrome | Among them there are a number of pSS associated gene polymorphisms including the... | BeFree | 26320362 | Detail |
0.002 | Premature Birth | NA | GAD | Detail | |
0.080 | Myocardial Ischemia | NA | BeFree,CTD_mouse | Detail | |
<0.001 | Cutaneous Melanoma | MHC class I chain-related gene a diversity in patients with cutaneous malignant ... | BeFree | 25838620 | Detail |
<0.001 | hypoplastic left heart syndrome | Unique to those in the D-HLHS group was increased β-MHC and decreased α-MHC prot... | BeFree | 24793904 | Detail |
0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | allergic asthma | Infection early in life is linked to persistent wheezing and allergic asthma in ... | BeFree | 25972545 | Detail |
<0.001 | Polyarthritis | NA | BeFree | Detail | |
<0.001 | Malnutrition | NA | BeFree | Detail | |
0.002 | Immunoglobulin A deficiency (disorder) | NA | BeFree | Detail | |
<0.001 | Liver Failure, Acute | NA | BeFree | Detail | |
<0.001 | MELAS syndrome | NA | BeFree | Detail | |
<0.001 | Aortic Aneurysm, Thoracic | NA | BeFree | Detail | |
0.003 | Autoimmune thyroid disease | NA | BeFree | Detail | |
0.002 | Tumor Progression | NA | BeFree | Detail | |
0.002 | Diabetes, Autoimmune | NA | BeFree | Detail | |
<0.001 | adenosquamous carcinoma | NA | BeFree | Detail | |
<0.001 | Giant Cell Tumor of Bone | NA | BeFree | Detail | |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | X-linked agammaglobulinemia | NA | BeFree | Detail | |
<0.001 | Chronic berylliosis | NA | BeFree | Detail | |
<0.001 | Adult type dermatomyositis | NA | BeFree | Detail | |
<0.001 | Hydrosalpinx (disease) | NA | BeFree | Detail | |
<0.001 | Inclusion Body Myositis (disorder) | NA | BeFree | Detail | |
0.005 | Cancer of Nasopharynx | NA | GAD | Detail | |
<0.001 | Papillary thyroid carcinoma | MHC class I loss is a frequent mechanism of immune escape in papillary thyroid c... | BeFree | 25294906 | Detail |
0.002 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
0.005 | Bare Lymphocyte Syndrome | NA | BeFree | Detail | |
<0.001 | pemphigus foliaceus | NA | BeFree | Detail | |
<0.001 | Pemphigus and fogo selvagem | NA | BeFree | Detail | |
0.001 | Psoriasis vulgaris | NA | BeFree | Detail | |
<0.001 | Dermatomyositis, Childhood Type | NA | BeFree | Detail | |
<0.001 | Congenital absence of adrenal gland | NA | BeFree | Detail | |
<0.001 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Spastic syndrome | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | Deletion of MHC II expression in macrophages led to an adipose tissue-specific d... | BeFree | 25310975 | Detail |
<0.001 | Postpartum Thyroiditis | NA | BeFree | Detail | |
<0.001 | Congenital immunodeficiency disease | NA | BeFree | Detail | |
<0.001 | Severe hereditary factor VIII deficiency disease | NA | BeFree | Detail | |
<0.001 | Mild hereditary factor VIII deficiency disease | NA | BeFree | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Metastatic Renal Cell Cancer | NA | BeFree | Detail | |
<0.001 | DS Stage I Plasma Cell Myeloma | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | Next, the first immune-activating anticytotoxic lymphocyte antigen-4 (CTLA-4) an... | BeFree | 25207460 | Detail |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of tonsil | NA | BeFree | Detail | |
<0.001 | Iron Overload | NA | BeFree | Detail | |
0.002 | cervix carcinoma | NA | BeFree | Detail | |
<0.001 | Tumor necrosis | This study was undertaken to investigate relationships between the HLA-E gene si... | BeFree | 26307125 | Detail |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
<0.001 | histiocytic sarcoma | NA | BeFree | Detail | |
<0.001 | Impaired cognition | NA | BeFree | Detail | |
<0.001 | Iodine deficiency syndrome | NA | BeFree | Detail | |
<0.001 | Hypophysitis | NA | BeFree | Detail | |
<0.001 | Multiple malignancy | NA | BeFree | Detail | |
<0.001 | Nonorganic psychosis | Replication and cross-phenotype study based upon schizophrenia GWASs data in the... | BeFree | 24888570 | Detail |
<0.001 | Cervical intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | Increased MHC-I expression may exacerbate the RSV disease condition due to immun... | BeFree | 25972545 | Detail |
<0.001 | New Variant Creutzfeldt-Jakob Disease | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
0.004 | Hereditary hemochromatosis | NA | BeFree | Detail | |
<0.001 | Immune thrombocytopenic purpura | Lack of impact of cytotoxic T-lymphocyte antigen 4 gene exon 1 polymorphism on s... | BeFree | 24023266 | Detail |
0.001 | Primary immune deficiency disorder | NA | BeFree | Detail | |
<0.001 | Steroid-sensitive nephrotic syndrome | The finding of a MHC class II locus underlying SSNS risk suggests a major role f... | BeFree | 25349203 | Detail |
<0.001 | adrenal cortical hypofunction | NA | BeFree | Detail | |
<0.001 | Actinic prurigo | NA | BeFree | Detail | |
<0.001 | Seropositive rheumatoid arthritis | NA | BeFree | Detail | |
0.002 | lupus erythematosus | NA | BeFree | Detail | |
<0.001 | Neonatal Systemic lupus erythematosus | NA | BeFree | Detail | |
<0.001 | Erythrokeratoderma | NA | BeFree | Detail | |
0.002 | combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Chronic active hepatitis | NA | BeFree | Detail | |
<0.001 | Hepatitis B, Chronic | NA | BeFree | Detail | |
<0.001 | Hepatitis C, Chronic | NA | BeFree | Detail | |
<0.001 | Hypersensitive syndrome | NA | BeFree | Detail | |
<0.001 | X-Linked Lymphoproliferative Disorder | NA | BeFree | Detail | |
<0.001 | Thyroid carcinoma | To evaluate MHC class I expression on papillary thyroid cancer (PTC) and analyze... | BeFree | 25294906 | Detail |
<0.001 | Oral infection | NA | BeFree | Detail | |
<0.001 | Malignant melanoma of eye | NA | BeFree | Detail | |
0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
<0.001 | Factor V Leiden mutation | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | lung sarcoma | NA | BeFree | Detail | |
<0.001 | monocytic leukemia | NA | BeFree | Detail | |
0.002 | prostate carcinoma | NA | BeFree | Detail | |
<0.001 | toxic shock syndrome | NA | BeFree | Detail | |
0.001 | Hashimoto Disease | NA | BeFree | Detail | |
<0.001 | Complete hydatidiform mole | NA | BeFree | Detail | |
0.005 | breast carcinoma | Here, we investigated a peptide-based vaccine, which consists of two MHC class I... | BeFree | 25104444 | Detail |
0.005 | breast carcinoma | The vaccines showed some efficacy in mice with sarcoma, melanoma, and breast can... | BeFree | 25792524 | Detail |
0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.004 | colon carcinoma | NA | BeFree | Detail | |
0.002 | stomach carcinoma | We identified that the HLA-E and HLA-F in gastric cancer independently affected ... | BeFree | 25862890 | Detail |
0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
0.002 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Acute anterior uveitis | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
0.002 | Hyperlipoproteinemia Type IIa | NA | BeFree | Detail | |
<0.001 | Parasitic infection | NA | BeFree | Detail | |
<0.001 | Scleroderma, Limited | NA | BeFree | Detail | |
<0.001 | Idiopathic Inflammatory Myopathies | NA | BeFree | Detail | |
0.001 | Inclusion Body Myopathy, Sporadic | NA | BeFree | Detail | |
<0.001 | Multiple Sclerosis, Relapsing-Remitting | NA | BeFree | Detail | |
<0.001 | Myasthenia Gravis, Autoimmune, Experimental | NA | BeFree | Detail | |
<0.001 | Lewy Body Disease | NA | BeFree | Detail | |
<0.001 | Gluten sensitivity | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
<0.001 | Carcinoma in situ of uterine cervix | NA | BeFree | Detail | |
<0.001 | 21-hydroxylase deficiency | NA | BeFree | Detail | |
<0.001 | Immunodeficiency congenital | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
0.001 | Acute GVH disease | HLA-E polymorphism did not affect the cumulative incidence of acute GVHD grades ... | BeFree | 25543014 | Detail |
<0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
<0.001 | latent infection | NA | BeFree | Detail | |
0.003 | Cardiomyopathies | NA | BeFree | Detail | |
<0.001 | Diffuse panbronchiolitis | NA | BeFree | Detail | |
<0.001 | Renal cancer metastatic | NA | BeFree | Detail | |
0.001 | autoimmune thyroiditis | NA | BeFree | Detail | |
<0.001 | Myasthenias | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Alloimmunisation | NA | BeFree | Detail | |
0.004 | Cardiomyopathy, Hypertrophic, Familial | NA | BeFree | Detail | |
0.001 | Spondylarthritis | Revisiting MHC genes in spondyloarthritis. | BeFree | 25903667 | Detail |
0.002 | Spondylarthropathies | NA | BeFree | Detail | |
0.002 | Arthritis, Collagen-Induced | NA | BeFree | Detail | |
<0.001 | West Nile viral infection | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | The levels of HLA-E protein expression in SOC patients with the HLA-E*0103 allel... | BeFree | 25711417 | Detail |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
<0.001 | diffuse scleroderma | NA | BeFree | Detail | |
0.002 | sarcoma | NA | BeFree | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | Persistent infection | NA | BeFree | Detail | |
<0.001 | Sporadic porphyria cutanea tarda | NA | BeFree | Detail | |
<0.001 | Enthesitis | NA | BeFree | Detail | |
<0.001 | Inflammatory disorder | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Generalized vitiligo | NA | BeFree | Detail | |
<0.001 | Herpes simplex type 1 infection | NA | BeFree | Detail | |
<0.001 | autoimmune vasculitis | NA | BeFree | Detail | |
<0.001 | Classical Hodgkin's Lymphoma | Enforced wild-type B2M expression in a cHL cell line restored MHC-I expression. | BeFree | 25488972 | Detail |
<0.001 | Primary Carcinoma | NA | BeFree | Detail | |
<0.001 | differentiated thyroid gland carcinoma | NA | BeFree | Detail | |
<0.001 | Mixed Neoplasm | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
<0.001 | Primary Glioblastoma | NA | BeFree | Detail | |
0.002 | Tumor Immunity | NA | BeFree | Detail | |
0.004 | colorectal cancer | Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-... | BeFree | 25461612 | Detail |
<0.001 | Latent Tuberculosis | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
<0.001 | Inflammatory polyarthritis | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
<0.001 | bone sarcoma | Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphi... | BeFree | 25000484 | Detail |
<0.001 | bone sarcoma | Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk... | BeFree | 25230787 | Detail |
<0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 2 | NA | BeFree | Detail | |
<0.001 | Recurrent bacterial infection | NA | BeFree | Detail | |
0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism ... | BeFree | 26013045 | Detail |
<0.001 | MAJOR AFFECTIVE DISORDER 1 | NA | BeFree | Detail | |
<0.001 | birdshot chorioretinopathy | This study further defined an extremely strong MHC risk component in BSCR, and d... | BeFree | 24957906 | Detail |
<0.001 | Severe Aplastic Anemia | NA | BeFree | Detail | |
<0.001 | Intravenous bisphosphonates | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
<0.001 | Myocardial Failure | NA | BeFree | Detail | |
<0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 4 | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 5 | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 6 | NA | BeFree | Detail | |
0.004 | liver carcinoma | NA | BeFree | Detail | |
<0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
<0.001 | ISS Stage I Plasma Cell Myeloma | NA | BeFree | Detail | |
<0.001 | autoimmune pancreatitis | NA | BeFree | Detail | |
<0.001 | myofibrillar myopathy | NA | BeFree | Detail | |
<0.001 | Major affective disorder 7 | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 8 | NA | BeFree | Detail | |
<0.001 | MAJOR AFFECTIVE DISORDER 9 | NA | BeFree | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
0.002 | Immunoglobulin a deficiency 1 | NA | BeFree | Detail | |
0.005 | Bare lymphocyte syndrome 2 | NA | BeFree | Detail | |
<0.001 | Juvenile dermatomyositis | NA | BeFree | Detail | |
0.003 | Nasopharyngeal carcinoma | There was a trend of reduced NPC risk in individuals who were homozygous for bot... | BeFree | 25636564 | Detail |
<0.001 | Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | NA | BeFree | Detail | |
<0.001 | complement component 4b deficiency | NA | BeFree | Detail | |
<0.001 | complement component 4a deficiency | NA | BeFree | Detail | |
<0.001 | plasmablastic lymphoma | NA | BeFree | Detail | |
0.002 | Juvenile arthritis | NA | BeFree | Detail | |
<0.001 | Allergic disposition | NA | BeFree | Detail | |
0.008 | Infection | NA | LHGDN | Detail | |
<0.001 | Staphylococcal toxic shock syndrome | NA | BeFree | Detail | |
0.002 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | AIDS (Disease) | NA | BeFree | Detail | |
0.002 | Spontaneous abortion | NA | GAD | Detail | |
<0.001 | Abscess | NA | BeFree | Detail | |
<0.001 | Addison Disease | NA | BeFree | Detail | |
<0.001 | adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Adrenal gland hypofunction | NA | BeFree | Detail | |
<0.001 | alopecia areata | NA | BeFree | Detail | |
<0.001 | Anemia, Pernicious | NA | BeFree | Detail | |
0.005 | Anemia, Sickle Cell | NA | GAD,LHGDN | Detail | |
<0.001 | anthrax disease | NA | BeFree | Detail | |
0.001 | arteriosclerosis | NA | BeFree | Detail | |
0.004 | arthritis | NA | BeFree | Detail | |
0.002 | Arthritis, Psoriatic | Significance of association of HLA-C and HLA-E with psoriatic arthritis. | BeFree | 25454626 | Detail |
0.017 | rheumatoid arthritis | The association to MHC class II (MHC-II) has been studied in several animal mode... | BeFree | 25672758 | Detail |
0.017 | rheumatoid arthritis | This study was undertaken to investigate relationships between the HLA-E gene si... | BeFree | 26307125 | Detail |
<0.001 | Aspergillosis, Allergic Bronchopulmonary | NA | BeFree | Detail | |
0.001 | asthma | NA | BeFree | Detail | |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
0.001 | atherosclerosis | NA | BeFree | Detail | |
<0.001 | autistic disorder | NA | BeFree | Detail | |
0.029 | Autoimmune Diseases | A considerable number of confirmed associations with RA and other autoimmune dis... | BeFree | 25189266 | Detail |
0.029 | Autoimmune Diseases | Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. | BeFree | 25216261 | Detail |
<0.001 | Melanoma, B16 | NA | BeFree | Detail | |
0.003 | Bacterial Infections | NA | BeFree,GAD | Detail | |
0.014 | Behcet Syndrome | Two recent genome-wide association studies (GWASs) of BD confirmed a strong asso... | BeFree,GAD,LHGDN | 25227143 | Detail |
0.014 | Behcet Syndrome | This study reinforces the notion that CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 a... | BeFree,GAD,LHGDN | 26097239 | Detail |
<0.001 | bipolar disorder | These data support shared risk SNPs between SCZ and BD in the Japanese populatio... | BeFree | 24888570 | Detail |
0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | Bone neoplasms | NA | BeFree | Detail | |
<0.001 | Brain Neoplasms | Here, we evaluated the use of an alternative approach that uses the proximity li... | BeFree | 25555220 | Detail |
0.005 | Malignant neoplasm of breast | Here, we investigated a peptide-based vaccine, which consists of two MHC class I... | BeFree | 25104444 | Detail |
0.005 | Malignant neoplasm of breast | The vaccines showed some efficacy in mice with sarcoma, melanoma, and breast can... | BeFree | 25792524 | Detail |
0.002 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | To evaluate MHC class I expression on papillary thyroid cancer (PTC) and analyze... | BeFree | 25294906 | Detail |
0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Repression of CELF-mediated splicing activity via expression of a nuclear dominant negative CELF pro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated with altered suscep... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-E alone and the comb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
A strong trend of association was also seen for 38 SNPs (P < 5 × 10(-5)) in the MHC region, supporti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MHC class II transcripts were reduced in CF with a sevenfold decrease in HLA-DQβ1 for CF-DQ(group2) ... | DisGeNET | Detail |
Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cyt... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we studied MHC class II expression on beta cells in nonobese diabetic mice that were induced to... | DisGeNET | Detail |
We demonstrate significant power in International Genetics & Translational Research in Transplantati... | DisGeNET | Detail |
Here we studied MHC class II expression on beta cells in nonobese diabetic mice that were induced to... | DisGeNET | Detail |
We demonstrate significant power in International Genetics & Translational Research in Transplantati... | DisGeNET | Detail |
Susceptibility to type 1 diabetes (T1D) is strongly associated with MHC class II molecules, particul... | DisGeNET | Detail |
Insulin is a major autoantigen in T1D, but how its peptides are presented to CD4 T cells by MHCII ri... | DisGeNET | Detail |
Our study indicates that MHC class II molecules may play an important role in beta-cell interaction ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In situ PLA showed that the IDH1R132H epitope colocalizes with MHC class II in IDH1R132H-mutated gli... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HLA-E*0103/E*0103 genotype is associated with lower risk of graft-versus-host disease, decreased mor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that therapeutic approaches using combined targeting of STAT1 and MHC class I ma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
On the basis of these findings, we propose that factors enabling a β2GPI-reactive T cell response ma... | DisGeNET | Detail |
Among them there are a number of pSS associated gene polymorphisms including the MHC-II, STAT4, IRF5... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We identified that the HLA-E and HLA-F in gastric cancer independently affected clinical factors, in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Exploration of peptides bound to MHC class I molecules in melanoma. | DisGeNET | Detail |
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A. | DisGeNET | Detail |
Data including and excluding Major Histocompatibility Complex (MHC) markers were summed to a MS Gene... | DisGeNET | Detail |
A mild line of MHC-CELFΔ mice that expresses a lower level of the dominant negative protein exhibits... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results also showed that the expression of HLA-E was significantly correlated with tumor metasta... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obe... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphisms in risk of bone ... | DisGeNET | Detail |
Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas. | DisGeNET | Detail |
The levels of HLA-E protein expression in SOC patients with the HLA-E*0103 allele were higher than t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, we show that the MHC and TNIP1 regions are significantly different in patients with pso... | DisGeNET | Detail |
Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vi... | DisGeNET | Detail |
Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A model is therefore proposed in which the host upregulates MHC-I expression during RSV infection di... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, three HLA alleles, all MHC class II proteins, were significantly associated with rosace... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The human MHC class I protein HLA-B*27:05 is statistically associated with ankylosing spondylitis, u... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, the potential application of pMHC to human stroke is limited by the need to rapidly match r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, our results provide evidence that the protozoan T. cruzi specifically modulates its ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A genome-wide significant association with cryoglobulin-related vasculitis was identified with SNPs ... | DisGeNET | Detail |
HLA-C is unique among the classical MHC class I molecules for its role in the control of viral infec... | DisGeNET | Detail |
Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Among them there are a number of pSS associated gene polymorphisms including the MHC-II, STAT4, IRF5... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southe... | DisGeNET | Detail |
Unique to those in the D-HLHS group was increased β-MHC and decreased α-MHC protein expression (MHC ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Infection early in life is linked to persistent wheezing and allergic asthma in later life, possibly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is revers... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deletion of MHC II expression in macrophages led to an adipose tissue-specific decrease in the effec... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Next, the first immune-activating anticytotoxic lymphocyte antigen-4 (CTLA-4) antibody ipilimumab ex... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study was undertaken to investigate relationships between the HLA-E gene single nucleotide poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased MHC-I expression may exacerbate the RSV disease condition due to immunopathologic damage, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lack of impact of cytotoxic T-lymphocyte antigen 4 gene exon 1 polymorphism on susceptibility to or ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The finding of a MHC class II locus underlying SSNS risk suggests a major role for immune response i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate MHC class I expression on papillary thyroid cancer (PTC) and analyze changes in MHC expr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we investigated a peptide-based vaccine, which consists of two MHC class II epitopes derived f... | DisGeNET | Detail |
The vaccines showed some efficacy in mice with sarcoma, melanoma, and breast cancer and activated MH... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We identified that the HLA-E and HLA-F in gastric cancer independently affected clinical factors, in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HLA-E polymorphism did not affect the cumulative incidence of acute GVHD grades II-IV at 100 days, t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Revisiting MHC genes in spondyloarthritis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The levels of HLA-E protein expression in SOC patients with the HLA-E*0103 allele were higher than t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Enforced wild-type B2M expression in a cHL cell line restored MHC-I expression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Kaplan-Meier analysis results showed that the expression levels of HLA-G or HLA-E alone and the comb... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Comprehensive evaluation of the cytotoxic T-lymphocyte antigen-4 gene polymorphisms in risk of bone ... | DisGeNET | Detail |
Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study further defined an extremely strong MHC risk component in BSCR, and detected evidence for... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
There was a trend of reduced NPC risk in individuals who were homozygous for both HLA-E(∗)01:03 and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Significance of association of HLA-C and HLA-E with psoriatic arthritis. | DisGeNET | Detail |
The association to MHC class II (MHC-II) has been studied in several animal models of RA. | DisGeNET | Detail |
This study was undertaken to investigate relationships between the HLA-E gene single nucleotide poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A considerable number of confirmed associations with RA and other autoimmune disease susceptibility ... | DisGeNET | Detail |
Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Two recent genome-wide association studies (GWASs) of BD confirmed a strong association with the MHC... | DisGeNET | Detail |
This study reinforces the notion that CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 are bona fide suscept... | DisGeNET | Detail |
These data support shared risk SNPs between SCZ and BD in the Japanese population and association be... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we evaluated the use of an alternative approach that uses the proximity ligation assay (PLA) t... | DisGeNET | Detail |
Here, we investigated a peptide-based vaccine, which consists of two MHC class II epitopes derived f... | DisGeNET | Detail |
The vaccines showed some efficacy in mice with sarcoma, melanoma, and breast cancer and activated MH... | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate MHC class I expression on papillary thyroid cancer (PTC) and analyze changes in MHC expr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs114465251 dbSNP
- Genome
- hg38
- Position
- chr6:30,489,509-30,494,194
- Variant Type
- snv
Genome browser